ITMR

COM:ITAMAR-MEDICAL

Itamar Medical

  • Stock

Last Close

30.87

01/01 00:00

Volume Today

1.02M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '17
Sep '17
Jun '18
Sep '18
Jun '19
Sep '19
Jun '20
Sep '20
Jun '21
Sep '21
net income
-1.13M
-
-1.39M
23.14%
-424K
69.58%
-1.20M
183.73%
-1.96M
62.76%
-1.15M
41.42%
-3.24M
182.65%
-2.76M
14.90%
-4.75M
72.02%
-7.98M
68.20%
depreciation and amortization
113K
-
122K
7.96%
128K
4.92%
108K
15.63%
343K
217.59%
385K
12.24%
479K
24.42%
456K
4.80%
921K
101.97%
875K
4.99%
deferred income tax
6K
-
4K
33.33%
15K
275%
96K
-
12K
87.50%
95K
-
40K
57.89%
452K
1,030%
stock based compensation
233K
-
385K
65.24%
269K
30.13%
257K
4.46%
355K
38.13%
355K
0%
372K
-
553K
48.66%
571K
3.25%
change in working capital
405K
-
-67K
116.54%
305K
555.22%
-429K
240.66%
-549K
27.97%
148K
126.96%
-1.42M
1,060.14%
-1.11M
21.75%
-1.86M
66.91%
2.55M
237.39%
accounts receivables
-121K
-
-304K
151.24%
659K
316.78%
-98K
114.87%
-251K
156.12%
388K
254.58%
-728K
287.63%
-867K
19.09%
-1.02M
17.19%
-1.92M
89.27%
inventory
56K
-
-349K
723.21%
-297K
14.90%
412K
238.72%
-247K
159.95%
-633K
156.28%
-1.02M
61.14%
-1.96M
91.96%
-479K
75.54%
98K
120.46%
accounts payables
389K
-
624K
60.41%
113K
81.89%
-613K
642.48%
147K
123.98%
199K
35.37%
151K
24.12%
782K
417.88%
-993K
226.98%
1.89M
290.33%
other working capital
81K
-
-38K
146.91%
-170K
347.37%
-130K
23.53%
-198K
52.31%
194K
197.98%
176K
9.28%
931K
428.98%
632K
32.12%
2.48M
293.20%
other non cash items
-426K
-
-326K
23.47%
-682K
109.20%
265K
138.86%
94K
64.53%
-28K
129.79%
4.18M
15,042.86%
41K
99.02%
216K
426.83%
-63K
129.17%
net cash provided by operating activities
-801K
-
-1.28M
59.30%
-389K
69.51%
-1.00M
157.58%
-1.62M
61.58%
-275K
83.01%
-2.91M
-
-4.87M
67.60%
-3.60M
26.15%
investments in property plant and equipment
-65K
-
-95K
46.15%
-65K
31.58%
-61K
6.15%
-116K
90.16%
-144K
24.14%
-478K
231.94%
-895K
87.24%
-552K
38.32%
-708K
28.26%
acquisitions net
purchases of investments
-9M
-
-8.50M
-
-32M
276.47%
sales maturities of investments
1.09M
-
other investing activites
25K
-
-20K
180%
-68K
-
-7.55M
11,002.94%
net cash used for investing activites
-40K
-
-115K
187.50%
-65K
43.48%
-61K
6.15%
-9.12M
14,844.26%
-212K
97.67%
-8.03M
3,686.79%
-9.39M
17.03%
-32.55M
246.48%
378K
101.16%
debt repayment
-435K
-
-215K
-
-146K
32.09%
-220K
50.68%
-220K
0%
-281K
27.73%
-182K
35.23%
common stock issued
5.21M
-
common stock repurchased
-38K
-
-479K
1,160.53%
dividends paid
other financing activites
53K
-
14K
-
-795K
-
51K
106.42%
143K
180.39%
37K
74.13%
net cash used provided by financing activities
53K
-
4.77M
-
-201K
-
-146K
27.36%
-1.01M
595.21%
-207K
79.61%
-617K
198.07%
-145K
76.50%
effect of forex changes on cash
237K
-
-69K
129.11%
-50K
27.54%
-9K
82%
65K
822.22%
43K
33.85%
-4K
-
140K
3,600%
51K
63.57%
net change in cash
-551K
-
-1.46M
164.97%
4.27M
392.47%
-1.07M
125.11%
-10.87M
914.09%
-590K
94.57%
-9.04M
1,432.71%
-12.51M
38.37%
-37.90M
202.89%
-3.31M
91.26%
cash at beginning of period
10.56M
-
10.01M
5.22%
4.26M
57.40%
8.53M
100.14%
19.89M
133.03%
9.02M
54.66%
37.67M
-
51.87M
37.71%
13.97M
73.07%
cash at end of period
10.01M
-
8.55M
14.59%
8.53M
0.18%
7.46M
12.56%
9.02M
20.83%
8.43M
6.54%
-9.04M
207.32%
25.15M
378.15%
13.97M
44.47%
10.65M
23.73%
operating cash flow
-801K
-
-1.28M
59.30%
-389K
69.51%
-1.00M
157.58%
-1.62M
61.58%
-275K
83.01%
-2.91M
-
-4.87M
67.60%
-3.60M
26.15%
capital expenditure
-65K
-
-95K
46.15%
-65K
31.58%
-61K
6.15%
-116K
90.16%
-144K
24.14%
-478K
231.94%
-895K
87.24%
-552K
38.32%
-708K
28.26%
free cash flow
-866K
-
-1.37M
58.31%
-454K
66.89%
-1.06M
134.14%
-1.74M
63.22%
-419K
75.85%
-478K
14.08%
-3.80M
695.40%
-5.42M
42.66%
-4.31M
20.61%

All numbers in (except ratios and percentages)